2019 Actinic Keratosis (Solar Keratosis) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 248 pages | ID: 2E1D22FB3D4EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Actinic Keratosis (Solar Keratosis) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Actinic Keratosis (Solar Keratosis). It presents in-depth analysis of Actinic Keratosis (Solar Keratosis) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Actinic Keratosis (Solar Keratosis).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Actinic Keratosis (Solar Keratosis) clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Actinic Keratosis (Solar Keratosis)

The research work is prepared through extensive and continuous research on Actinic Keratosis (Solar Keratosis) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Actinic Keratosis (Solar Keratosis) patients are identified
• The report includes panorama of Actinic Keratosis (Solar Keratosis) clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Actinic Keratosis (Solar Keratosis) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Actinic Keratosis (Solar Keratosis) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Actinic Keratosis (Solar Keratosis) Clinical Trials by Region
  2.2.2 Average Enrollment of Actinic Keratosis (Solar Keratosis) Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Actinic Keratosis (Solar Keratosis) Treatment, 2019

3. REGION WISE ACTINIC KERATOSIS (SOLAR KERATOSIS) CLINICAL TRIALS

3.1 Asia Pacific Actinic Keratosis (Solar Keratosis) Clinical Trials by Country
3.2 Europe Actinic Keratosis (Solar Keratosis) Clinical Trials by Country
3.3 North America Actinic Keratosis (Solar Keratosis) Clinical Trials by Country
3.4 Middle East and Africa Actinic Keratosis (Solar Keratosis) Clinical Trials by Country
3.5 South and Central America Actinic Keratosis (Solar Keratosis) Clinical Trials by Country

4. ACTINIC KERATOSIS (SOLAR KERATOSIS) CLINICAL TRIAL TRENDS

4.1 Start Year wise Actinic Keratosis (Solar Keratosis) Clinical Trials
4.2 Phase wise Actinic Keratosis (Solar Keratosis) Clinical Trials
4.3 Trial Status wise Actinic Keratosis (Solar Keratosis) Clinical Trials
4.4 Trial Type wise Actinic Keratosis (Solar Keratosis) Clinical Trials

5. ACTINIC KERATOSIS (SOLAR KERATOSIS) AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Actinic Keratosis (Solar Keratosis) Trials by Year
5.2 Average Enrollment in Actinic Keratosis (Solar Keratosis) Trials by Phase
5.3 Average Enrollment in Actinic Keratosis (Solar Keratosis) Trials by Status
5.4 Average Enrollment in Actinic Keratosis (Solar Keratosis) Trials by Type of Trial

6. COMPANIES PARTICIPATING IN ACTINIC KERATOSIS (SOLAR KERATOSIS) CLINICAL TRIALS

6.1 Actinic Keratosis (Solar Keratosis) Trials by Sponsor Type
6.2 Actinic Keratosis (Solar Keratosis) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Actinic Keratosis (Solar Keratosis) Trials- Phase
7.2 Actinic Keratosis (Solar Keratosis) Trials- Phase
7.3 Actinic Keratosis (Solar Keratosis) Trials- Phase
7.4 Actinic Keratosis (Solar Keratosis) Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Actinic Keratosis (Solar Keratosis) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Actinic Keratosis (Solar Keratosis) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Actinic Keratosis (Solar Keratosis) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Actinic Keratosis (Solar Keratosis) Clinical Trials and Enrolment
Figure 7: North America – Country wise Actinic Keratosis (Solar Keratosis) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Actinic Keratosis (Solar Keratosis) Clinical Trials and Enrolment
Figure 9: Actinic Keratosis (Solar Keratosis) Clinical Trials by Phase
Figure 10: Actinic Keratosis (Solar Keratosis) Clinical Trials by Trial Status
Figure 11: Actinic Keratosis (Solar Keratosis) Clinical Trials by Type
Figure 12: Actinic Keratosis (Solar Keratosis) Clinical Trials by Sponsor Type
Figure 13: Actinic Keratosis (Solar Keratosis) Clinical Trials by Leading Sponsors
Figure 14: Actinic Keratosis (Solar Keratosis) Average Enrollment by Phase
Figure 15: Actinic Keratosis (Solar Keratosis) Average Enrollment by Trial Status
Figure 16: Actinic Keratosis (Solar Keratosis) Average Enrollment by Type
Figure 17: Actinic Keratosis (Solar Keratosis)- Average Enrolment by Type of Sponsors
Figure 18: Actinic Keratosis (Solar Keratosis)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Actinic Keratosis (Solar Keratosis) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Actinic Keratosis (Solar Keratosis) Clinical Trials and Enrolment
Table 5: Europe – Country wise Actinic Keratosis (Solar Keratosis) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Actinic Keratosis (Solar Keratosis) Clinical Trials and Enrolment
Table 7: North America – Country wise Actinic Keratosis (Solar Keratosis) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Actinic Keratosis (Solar Keratosis) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Actinic Keratosis (Solar Keratosis) Average Enrollment by Phase
Table 15: Actinic Keratosis (Solar Keratosis) Average Enrollment by Trial Status
Table 16: Actinic Keratosis (Solar Keratosis) Average Enrollment by Type
Table 17: Actinic Keratosis (Solar Keratosis)- Average Enrolment by Type of Sponsors
Table 18: Actinic Keratosis (Solar Keratosis)- Enrolment by Leading Sponsors